Can-Fite BioPharma (CANF) Return on Assets [ROA] (2013 - 2023)
Can-Fite BioPharma's Return on Assets [ROA] was -105.48% in FY2025, down 23.01 percentage points from -82.47% in FY2024.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Return on Assets [ROA] (2013 - 2023) Analysis & Trends
From FY2013 onward, Can-Fite BioPharma has reported Return on Assets [ROA] for 13 years.
- Return on Assets [ROA] has now declined for three consecutive years, though with a five-year change of +57.74 percentage points (FY2020 to FY2025).
- The FY2025 figure marks the lowest annual Return on Assets [ROA] since FY2020.
- Per Business Quant data, Return on Assets [ROA] in earlier years was -82.47% in FY2024 (-3.25 pp), -79.22% in FY2023 (-27.53 pp), -51.69% in FY2022 (+33.04 pp) and -84.73% in FY2021 (+78.49 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Can-Fite BioPharma | 2.16 Mn | -17.54 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -82.58% |
| Sep 30, 2023 | -66.71% |
| Jun 30, 2023 | -61.21% |
| Mar 31, 2023 | -69.49% |
| Dec 31, 2022 | -69.43% |
| Sep 30, 2022 | -82.12% |
| Jun 30, 2022 | -74.51% |
| Mar 31, 2022 | -69.14% |
| Dec 31, 2021 | -72.31% |
| Sep 30, 2021 | -99.76% |
| Jun 30, 2021 | -100.84% |
| Mar 31, 2021 | -107.60% |
| Dec 31, 2020 | -103.70% |
| Sep 30, 2020 | -85.45% |
| Jun 30, 2020 | -146.01% |
| Dec 31, 2019 | -96.23% |
| Sep 30, 2019 | -88.68% |
| Jun 30, 2019 | -80.35% |
| Mar 31, 2019 | -83.67% |
| Dec 31, 2018 | -69.99% |
API Access
Can-Fite BioPharma Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();